Helix BioPharma
(OTC) HBPCF
Helix BioPharma Financials at a Glance
Market Cap
$132.13M
Revenue (TTM)
$0.00
Net Income (TTM)
$4.25M
EPS (TTM)
$-0.05
P/E Ratio
-37.69
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.73
Volume
100
Open
$1.73
Price
$1.73
Volume
100
Open
$1.73
Previous Close
$1.73
Daily Range
$1.73 - $1.73
52-Week Range
$0.45 - $1.73
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.73
Volume
100
Open
$1.73
Previous Close
$1.73
Daily Range
$1.73 - $1.73
52-Week Range
$0.45 - $1.73
HBPCF News
HBPCF: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Helix BioPharma
Industry
Biotechnology
Sector
Health CareEmployees
7
CEO
Thomas Mehrling, MD, PhD
Website
www.helixbiopharma.comHeadquarters
Toronto, ON M5H 2Y4, CA
HBPCF Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
-53%
Return on Capital
-27%
Return on Assets
-23%
Earnings Yield
-2.65%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$132.13M
Shares Outstanding
76.38M
Volume
100
Short Interest
0.00%
Avg. Volume
6.377
Financials (TTM)
Gross Profit
$0.00
Operating Income
$5.00M
EBITDA
$5.00M
Operating Cash Flow
$4.00M
Capital Expenditure
$0.00
Free Cash Flow
$4.00M
Cash & ST Invst.
$64.64K
Total Debt
$333.15K
Helix BioPharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$1.00K
N/A
Gross Margin
0.00%
N/A
Market Cap
$132.13M
N/A
Market Cap/Employee
$18.88M
N/A
Employees
7
N/A
Net Income
$695.09K
+49.4%
EBITDA
$682.07K
+50.2%
Quarterly Fundamentals
Net Cash
$328.52K
-116.5%
Accounts Receivable
$25.04K
-89.4%
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$359.56K
N/A
Return on Assets
-22.65%
N/A
Return on Invested Capital
-27.11%
N/A
Free Cash Flow
$456.72K
+51.5%
Operating Cash Flow
$456.72K
+51.4%